CHENYSEServices-Home Health Care ServicesFiscal year ends December 31
CHEMED CORP
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 31, 2026
$508.29−4.09 (-0.80%)
Close on Oct 19, 2026
- Market cap
- $6.71B
- P/E (TTM)
- 25.5
- Dividend yield
- 0.43%
CHEMED CORP revenue by segment
By business segment
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| VITAS [Member] | $1.63B | $1.53B | $1.32B | $1.20B | – | – | – | $1.20B | $1.15B | $1.12B | 64.4% | +6.5% |
| Roto-Rooter [Member] | $899.88M | $900.31M | $949.35M | $933.40M | $878.02M | $744.92M | $657.37M | $585.09M | $518.46M | $453.56M | 35.6% | -0.0% |
| Operating income | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| VITAS [Member] | $246.94M | $263.97M | $184.10M | $155.12M | – | – | – | – | – | – | -6.5% |
| Roto-Rooter [Member] | $160.83M | $194.52M | $226.76M | $235.73M | – | – | – | – | – | – | -17.3% |
| Corporate [Member] | – | -$91.99M | -$70.29M | -$47.36M | – | – | – | – | – | – | – |
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All Other Revenue- Self-pay, Respite Care, Etc. [Member] | – | $19.46M | $13.58M | $12.44M | $12.14M | $11.16M | $10.43M | $7.83M | – | – | – | – |
| Franchise [Member] | – | – | – | – | – | – | $6.10M | $6.38M | – | – | – | – |
| Continuous Care [Member] | – | $99.75M | $85.67M | $77.00M | $94.34M | $136.01M | $133.47M | – | – | – | – | – |
| Care Services Total [Member] | – | $1.55B | $1.33B | $1.22B | $1.28B | $1.36B | $1.31B | – | – | – | – | – |
| Inpatient Care [Member] | – | $120.60M | $112.42M | $102.36M | $113.19M | $114.96M | $99.92M | – | – | – | – | – |
| Routine Home Care [Member] | – | $1.33B | $1.14B | $1.04B | $1.07B | $1.11B | $1.08B | – | – | – | – | – |
By region
From the segment and revenue-disaggregation notes of Chemed's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.